What do I need to know about daraxonrasib, the new treatment for pancreatic cancer?
General Health Treatments
Heather Duncan, MPH, PhD
A new drug called daraxonrasib nearly doubled survival time for patients enrolled in a phase-3 clinical trial. That’s a big deal, because treatment options for pancreatic cancer are limited and survival rates at 5 years are very low. In 2002, my grandmother was diagnosed with pancreatic cancer. Six months later she was admitted to hospice, Read more…
A new drug called daraxonrasib nearly doubled survival time for patients enrolled in a phase-3 clinical trial. That’s a big deal, because treatment options for pancreatic cancer are limited and survival rates at 5 years are very low. In 2002, my grandmother was diagnosed with pancreatic cancer. Six months later she was admitted to hospice, Read more…
